Case number 1:22-cv-00354
AstraZeneca AB et al v. Alkem Laboratories Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 24, 2022 | 17 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT (see Judgment for further details). Signed by Judge Richard G. Andrews on 6/24/2022. (nms) |
| Jun 24, 2022 | 18 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 46,276; 10,300,065. (Attachments: # (1) Consent Judgment)(nms) |
| Jun 24, 2022 | 18 | Consent Judgment (4) |
| Jun 23, 2022 | 16 | Proposed Consent Judgment (4) Docket Text: PROPOSED Consent Judgment, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) Modified on 6/23/2022 (nms). |
| Jun 21, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 24 in 21-cv-1116-RGA; D.I. 15 in 22-cv-354-RGA; D.I. 17 in 21-cv-1284-RGA) MOTION for Pro Hac Vice Appearance of Attorney Ryan P. O'Quinn and Mark J. Feldstein, filed by AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 6/21/2022. Associated Cases: 1:21-cv-01116-RGA, 1:21-cv-01284-RGA, 1:22-cv-00354-RGA(nms) |
| Jun 21, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Mark J. Feldstein and Ryan P. O'Quinn for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 20, 2022 | 15 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ryan P. O'Quinn and Mark J. Feldstein - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # (1) Certifications for Ryan P. O'Quinn and Mark J. Feldstein)(Silver, Daniel) |
| Jun 20, 2022 | 15 | Certifications for Ryan P. O'Quinn and Mark J. Feldstein (2) |
| Jun 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Alkem Laboratories Limited answer due 7/13/2022; S&B Pharma, Inc. answer due 7/13/2022). Signed by Judge Richard G. Andrews on 6/13/2022. (nms) |
| Jun 13, 2022 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Alkem Laboratories Limited. (Stamoulis, Stamatios) Modified on 6/13/2022 (nms). |
| May 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Alkem Laboratories Limited answer due 6/13/2022; S&B Pharma, Inc. answer due 6/13/2022). Signed by Judge Richard G. Andrews on 5/11/2022. (nms) |
| May 11, 2022 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to ANSWER Complaint to June 13, 2022 - filed by Alkem Laboratories Limited. (Stamoulis, Stamatios) |
| Apr 28, 2022 | 12 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Angela C. Whitesell as co-counsel.. (Silver, Daniel) |
| Apr 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Alkem Laboratories Limited answer due 5/11/2022; S&B Pharma, Inc. answer due 5/11/2022). Signed by Judge Richard G. Andrews on 4/11/2022. (nms) |
| Apr 9, 2022 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Alkem Laboratories Limited, S&B Pharma, Inc.. (Stamoulis, Stamatios) Modified on 4/11/2022 (nms). |
| Mar 25, 2022 | 9 | Main Document (2) Docket Text: DECLARATION of Service of Alkem Laboratories Ltd., by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 3/25/2022 (nms). |
| Mar 25, 2022 | 9 | Exhibit A-B (7) |
| Mar 25, 2022 | 10 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. S&B Pharma, Inc. served on 3/21/2022, answer due 4/11/2022. (Joyce, Alexandra) |
| Mar 23, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Mar 18, 2022 | 1 | Main Document (14) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Alkem Laboratories Limited, S&B Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3828706.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(srs) |
| Mar 18, 2022 | 1 | Exhibit A-C (111) |
| Mar 18, 2022 | 1 | Civil Cover Sheet (3) |
| Mar 18, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Mar 18, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than February 1, 2022. Date of Expiration of Patent: RE46,276 - 10/30/2024; 10,300,065 - 1/27/2036. Thirty Month Stay Deadline: No earlier than August 1, 2024. (srs) |
| Mar 18, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,276 ;10,300,065. (srs) |
| Mar 18, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca UK Limited filed by AstraZeneca UK Limited. (srs) |
| Mar 18, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (srs) |
| Mar 18, 2022 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (srs) |
| Mar 18, 2022 | 8 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (srs) |
| Mar 18, 2022 | 1 | Complaint* (1) |
